Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/4RY stock hub

FRA/4RY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/4RYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13.4B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/4RY

In the news

Latest news · FRA/4RY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E187.9

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-14.5

P25 n/aP50 n/aP75 n/a

ROIC-23

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/4RY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

167

Groups with data

Currency

CNY

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	DE
Employees	3,761
Employees Change	494%
Employees Change Percent	16.28
Enterprise value	EUR 12.8B
Exchange	Frankfurt Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 13.4B
Price	EUR 14.5
Price currency	EUR
Rev Per Employee	98,952.16x
Sic	2836
Symbol	fra/4RY
Website	https://www.akesobio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.01%
EV Earnings	-94.63x
EV/FCF	-61.08x
EV/Sales	34.75x
FCF yield	-1.57%
Forward P/E	187.88x
P/B ratio	12.3x
P/S ratio	35.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-32.53%
EBITDA Margin	-24.61%
Gross margin	77.45%
Gross Profit	EUR 288.2M
Gross Profit Growth	18.94%
Gross Profit Growth Q	42.59%
Gross Profit Growth3 Y	11.06%
Gross Profit Growth5 Y	-10.83%
Net Income	EUR -135.5M
Pretax Margin	-37.33%
Profit Margin	-36.42%
Profit Per Employee	EUR -36,036
ROA	-4.32
Roa5y	-6.35
ROCE	-7.2
ROE	-14.53
Roe5y	-10.93
ROIC	-22.98
Roic5y	-35.37

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	55.07%
Cagr3y	42.96%
Cagr5y	23%
Revenue Growth	43.9x
Revenue Growth Q	49.63x
Revenue Growth3 Y	17.71x
Revenue Growth5 Y	-6.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.21
Assets	EUR 1.9B
Cash	EUR 1.1B
Current Assets	EUR 1.4B
Current Liabilities	EUR 273.7M
Debt	EUR 554.8M
Debt Equity	EUR 0.51
Debt FCF	EUR -2.64
Equity	EUR 1.1B
Interest Coverage	-7.59
Liabilities	EUR 859M
Long Term Assets	EUR 542.2M
Long Term Liabilities	EUR 585.3M
Net Cash	EUR 562.5M
Net Cash By Market Cap	EUR 4.2
Net Cash Growth	35.98%
Net Debt Equity	EUR -0.52
Tangible Book Value	EUR 1.1B
Tangible Book Value Per Share	EUR 1.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.14
Inventory Turnover	0.84
Net Working Capital	EUR 60.8M
Quick ratio	4.7
Working Capital	EUR 1.1B
Working Capital Turnover	EUR 0.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.09%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	55.03%
200-day SMA	13.83
3Y total return	192.24%
50-day SMA	13.49
50-day SMA vs 200-day SMA	50under200
5Y total return	181.46%
All Time High	19.3
All Time High Change	-24.9%
All Time High Date	2025-08-22
All Time Low	1.39
All Time Low Change	942.81%
All Time Low Date	2022-03-15
ATR	0.44
Ch YTD	20.79
High	14.54
High52	19.3
High52 Date	2025-08-22
High52ch	-24.9%
Low	14.5
Low52	8.2
Low52 Date	2025-06-02
Low52ch	76.77%
Ma50ch	7.49%
Price vs 200-day SMA	4.78%
RSI	50.56
RSI Monthly	62.71
RSI Weekly	57.02
Sharpe ratio	0.63x
Sortino ratio	1.06
Total Return	-6.09%
Tr YTD	20.79
Tr1m	-1.76%
Tr1w	5.92%
Tr3m	35.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -121M
Operating margin	-32.53

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	721,813,552%
Net Borrowing	80,187,445.2
Shares Insiders	18.14%
Shares Institutions	32.9%
Shares Qo Q	1.72%
Shares Yo Y	6.09%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -229.1M
Average Volume	82.5x
Bv Per Share	1.2
CAPEX	EUR -94.6M
Ch1m	-1.76
Ch1w	5.92
Ch1y	55.03
Ch3m	35.47
Ch3y	192.2
Ch5y	181.5
Ch6m	17.85
Change	-2.69%
Change From Open	-0.21
Close	14.9
Days Gap	-2.48
Depreciation Amortization	30,150,605.1
Earnings Date	2026-08-26
EBIT	EUR -121M
EBITDA	EUR -91.6M
EPS	EUR -0.15
F Score	4
FCF	EUR -210M
FCF EV Yield	-1.64x
Financing CF	421,105,887
Fiscal Year End	December
Founded	2,012
Investing CF	-500,842,440
Is Primary Listing	0
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Ma150	13.03
Ma150ch	11.21%
Ma20	14.94
Ma20ch	-3%
Net CF	-199,203,478
Next Earnings Date	2026-08-26
Open	14.53
Position In Range	0
Ppne	523,556,311.8
Price Date	2026-05-08
Ptbv Ratio	12.18
Relative Volume	45.71x
Revenue	372,159,074x
SBC By Revenue	5.14x
Share Based Comp	19,119,535
Tr6m	17.85%
Z Score	7.76

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/4RY pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/4RY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/4RY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+32.9%

Share of float held by funds and institutions

Insider ownership

+18.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+6.1%

Negative means the company is buying back shares.

Technical

FRA/4RY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.6

Neutral momentum band

Price vs 200-day MA

+4.8%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.63

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/4RY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/4RY stock rating?

fra/4RY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/4RY analysis?

The full report lives at /stocks/fra/4RY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/4RY?

The latest report frames fra/4RY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/4RY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.